Anatara Lifesciences (ASX:ANR), a developer of evidence based solutions for gastrointestinal health in humans and animals, invites shareholders to attend a virtual group briefing with Chief Executive Officer, Steven Lydeamore, on Thursday 9 September 2021 at 11:00am AEST.
Hosted by Market Eye, Mr Lydeamore will provide an update on the Company's latest developments and market opportunities. Shareholders will have an opportunity to ask questions at the end of the briefing.
Attendance is free; however, registration is required. Register to attend at:
Steven Lydeamore CEO, Anatara Lifesciences Ltd +61 (0) 438 027 172 email@example.com Eric Kuret Market Eye +61 (0) 417 311 335 firstname.lastname@example.org
News Provided by ABN Newswire